United States · FDA National Drug Code directory
ASPIRIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50332-0139_356da65e-7683-4116-aaef-a4c8decd1297
- Product NDC
- 50332-0139
- Form
- TABLET
- Composition / generic term
- ASPIRIN
- Labeler
- HART Health
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20230101
- Source listing expiry
- 20271231
Source-listed ingredients
- ASPIRIN — 325 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25 PACKET in 1 BOX, UNIT-DOSE (50332-0139-3) / 2 TABLET in 1 PACKET · 50332-0139-3
- 50 PACKET in 1 BOX, UNIT-DOSE (50332-0139-4) / 2 TABLET in 1 PACKET · 50332-0139-4
- 125 PACKET in 1 BOX, UNIT-DOSE (50332-0139-7) / 2 TABLET in 1 PACKET · 50332-0139-7
- 250 PACKET in 1 BOX, UNIT-DOSE (50332-0139-8) / 2 TABLET in 1 PACKET · 50332-0139-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →